CD58 expression decreases as nonmalignant B cells mature in bone marrow and is frequently overexpressed in adult and pediatric precursor B-cell acute lymphoblastic leukemia

American Journal of Clinical Pathology

Volumn 123, Issue 1, 2005, Pages 119-124

  Lee, Ronald V ^a   Braylan, Raul C ^a   Rimsza, Lisa M ^a,b,c  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

Author keywords

Acute lymphoblastic leukemia; CD2 ligand; CD58; Hematogones; LFA 3; Precursor B cell

Indexed keywords

CD2 ANTIGEN; LIGAND; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BLAST CELL; BONE MARROW; CANCER CELL; CELL MATURATION; CHILD; CHILDHOOD LEUKEMIA; CONTROLLED STUDY; DIAGNOSTIC VALUE; FLOW CYTOMETRY; FLUORESCENCE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; PATIENT MONITORING; PRIORITY JOURNAL; PROLYMPHOCYTE;

EID: 11244279815     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/X5VV6FKJQ6MUBLPX     Document Type: Article

References (19)

1. Bullens DM, Rafiq K, Charitidou L, et al. Effects of co-stimulation by CD58 on human T cell cytokine production: a selective cytokine pattern with induction of high IL-10 production. Int Immunol. 2001;13:181-191.
2. Gollob JA, Ritz J. CD2-CD58 interaction and the control of T-cell interleukin-12 responsiveness: adhesion molecules link innate and acquired immunity. Ann N Y Acad Sci. 1996;795:71-81.
3. Webb DS, Shimizu Y, Van Seventer GA, et al. LFA-3, CD44, and CD45: physiologic triggers of human monocyte TNF and IL-1 release. Science. 1990;249:1295-1297.
4. Decker T, Schneller F, Sparwasser T, et al. Immunostimulatory CpG-oligonucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood. 2000;95:999-1006.
5. Imai T, Tanaka Y, Fukudome K, et al. Enhanced expression of LFA-3 on human T-cell lines and leukemic cells carrying human T-cell-leukemia virus type 1. Int J Cancer. 1993;55:811-816.
6. Delabie J, Chan WC, Weisenburger DD, et al. The antigen-presenting cell function of Reed-Stemberg cells. Leuk Lymphoma. 1995;18:35-40.
7. Tatsumi T, Shimazaki C, Goto H, et al. Expression of adhesion molecules on myeloma cells. Jpn J Cancer Res. 1996;87:837-842.
8. Reuss-Borst MA, Buhring HJ, Klein G, et al. Adhesion molecules on CD34+ hematopoietic cells in normal human bone marrow and leukemia. Ann Hematol. 1992;65:169-174.
9. De Waele M, Renmans W, Jochmans K, et al. Different expression of adhesion molecules on CD34+ cells in AML and B-lineage ALL and their normal bone marrow counterparts. Eur J Haematol. 1999;63:192-201.
10. Chen JS, Coustan-Smith E, Suzuki T, et al. Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia. Blood. 2001;97:2115-2120.
11. Veltroni M, De Zen L, Sanzari MC, et al. Expression of CD58 in normal, regenerating and leukemic bone marrow B cells: implications for the detection of minimal residual disease in acute lymphocytic leukemia. Haematologica. 2003;88:1245-1252.
12. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis: use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol. 1993;100:534-540.
13. McKenna RW, Washington LT, Aquino DB, et al. Immunophenotypic analysis of hematogones (B-lymphocyte precursors) in 662 consecutive bone marrow specimens by 4-color flow cytometry. Blood. 2001;98:2498-2507.
14. Rimsza LM, Larson RS, Winter SS, et al. Benign hematogone-rich lymphoid proliferations can be distinguished from B-lineage acute lymphoblastic leukemia by integration of morphology, immunophenotype, adhesion molecule expression, and architectural features. Am J Clin Pathol. 2000;114:66-75.
15. Stelzer GT, Marti G, Hurley A, et al. US-Canadian Consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry. 1997;30:214-230.
16. van Hooijdonk CA, Glade CP, van Erp PE. TO-PRO-3 iodide: a novel HeNe laser-excitable DNA stain as an alternative for propidium iodide in multiparameter flow cytometry. Cytometry. 1994;17:185-189.
17. Nicholson JK, Hubbard M, Jones BM. Use of CD45 fluorescence and side-scatter characteristics for gating lymphocytes when using the whole blood lysis procedure and flow cytometry. Cytometry. 1996;26:16-21.
18. Stelzer GT, Shults KE, Loken MR. CD45 gating for routine flow cytometric analysis of human bone marrow specimens. Ann NY Acad Sci. 1993;677:265-280.
19. Archimbaud E, Campos L, Vila L, et al. Potential role for non-HLA-restricted cytotoxic cells in the immune surveillance of acute leukemia. Immunol Lett. 1993;39:13-15.